Evidence map›Paper›PMID 26711767›Full record

ArticleAntimicrobial agents and chemotherapy2015

Key Roles of Human Polymorphonuclear Cells and Ciprofloxacin in Lactobacillus Species Infection Control.

Narcisa Mandras, Vivian Tullio, Pio Maria Furneri, Janira Roana, Valeria Allizond, Daniela Scalas, Giulio Petronio Petronio, Virginia Fuochi, Giuliana Banche, Anna Maria Cuffini

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-ResistantInternational journal of molecular sciences · 2023
    Article
  3. Association between Perceived Stress and Neutropenia in Patients with Leukemia under Chemotherapy.International journal of hematology-oncology and stem cell research · 2022
    Article
  4. Techno-functional characterization of indigenousCurrent research in food science · 2020
    Article
  5. Article
  6. Enhanced Killing ofMolecules (Basel, Switzerland) · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Narcisa MandrasMicrobiology Division, Department of Public Health and Paediatrics, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0002-2949-4556
Vivian TullioMicrobiology Division, Department of Public Health and Paediatrics, University of Turin, Turin, Italy vivian.tullio@unito.it.ORCID http://orcid.org/0000-0002-8660-4248
Pio Maria FurneriMicrobiology Section, Department of Bio-Medical Sciences, University of Catania, Catania, Italy.ORCID http://orcid.org/0000-0003-1782-9758
Janira RoanaMicrobiology Division, Department of Public Health and Paediatrics, University of Turin, Turin, Italy.
Valeria AllizondMicrobiology Division, Department of Public Health and Paediatrics, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0003-0585-9247
Daniela ScalasMicrobiology Division, Department of Public Health and Paediatrics, University of Turin, Turin, Italy.
Giulio Petronio PetronioMicrobiology Section, Department of Bio-Medical Sciences, University of Catania, Catania, Italy BioBIM-Multidisciplinary Interinstitutional BioBank, IRCCS San Raffaele Pisana, Rome, Italy.
Virginia FuochiMicrobiology Section, Department of Bio-Medical Sciences, University of Catania, Catania, Italy.
Giuliana BancheMicrobiology Division, Department of Public Health and Paediatrics, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0003-2219-0223
Anna Maria CuffiniMicrobiology Division, Department of Public Health and Paediatrics, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0002-2698-164X
University of Turin · ITUniversity of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactobacilli have the potential to act as reservoirs of antibiotic resistance genes similar to those found in human pathogens, with the risk of transferring these genes to many pathogenic bacteria. In this study, we investigated the role of human polymorphonuclear cells (PMNs) against Lactobacillus spp. both resistant and susceptible to ciprofloxacin (a fluoroquinolone) and the effect of ciprofloxacin on the interaction between PMNs and three Lactobacillus spp. with different patterns of susceptibility to this drug. Hence, the primary functions of PMNs, such as phagocytosis and bacterial intracellular killing, against lactobacilli were investigated. The rate of PMN phagocytosis was high for ciprofloxacin-sensitive and ciprofloxacin-resistant strains. The patterns of intracellular killing of ciprofloxacin-sensitive and ciprofloxacin-resistant strains by PMNs underline that PMNs alone were able to kill lactobacilli. The addition of ciprofloxacin to PMNs did not result in a significant increase in the bacterial uptake by phagocytes. On the contrary, ciprofloxacin had a marked effect on PMN intracellular killing, resulting in increased numbers of killed ciprofloxacin-sensitive bacteria in comparison with antibiotic-free controls. Our data show that by itself, the profile of antibiotic resistance does not constitute an intrinsic factor of greater or lesser pathogenicity toward the host. The ability of PMNs to kill a diverse array of bacterial pathogens is essential for human innate host defense, primarily in immunocompromised patients.

Indexed as

Anti-Bacterial AgentsCells, CulturedCiprofloxacinDrug Resistance, Multiple, BacterialGene Transfer, HorizontalHumansLactobacillusNeutrophilsPhagocytosisAnti-Bacterial AgentsCiprofloxacin

Identifiers

PMID26711767
PMCPMC4775954
OpenAlexW2278765666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.